摘要
流行病学、血清学和分子生物学的资料证实,爱泼斯坦-巴尔病毒(EBV感染与鼻咽癌(NPC)有密切关系。血清EBV-VCA-IgA,EBV-EA-IgA测定和聚合酶链(PCR)检测组织中EBV-DNA已用于NPC的临床诊断。本文评价上述方法在NPC诊断中的实用价值。85例病人双盲法测定血清EBV-VCA-IgA(I),EBV-EA-IgA(Ⅱ):鼻咽活检组织用PCR法检测EBV-DNA(Ⅲ)和组织病理检测(Ⅳ)。组织病理学证实:NPC57例;非NPC28例作为对照组。57例NPC中,(Ⅰ)、(Ⅱ)、(Ⅲ)的阳性率分别为66.7%,21.1%,80.7%;(Ⅰ)+(Ⅱ),(Ⅰ)+(Ⅲ),(Ⅱ)+(Ⅲ)或(Ⅰ)+(Ⅱ)+(Ⅲ)的阳性率分别为21.1%,56.1%,19.3%,19.3%(P<0.005)。28例对照组(Ⅰ)、(Ⅱ)或(Ⅲ)的阴性率分别为75%,100%,100%;(Ⅰ)+(Ⅱ),(Ⅰ)+(Ⅲ),或(Ⅰ)+(Ⅱ)+(Ⅲ)均为对.4%(P<0.005)。本组结果提示,PCR法检测EBV-DNA具有灵敏度高(NPC的阳性率高)和特异性强(对照组的阴性率高)的特点。
It is well known that Epstein-Bars virus (EBV) has been linked to nasopharyngeal carcinoma (NPC) on the basis of epidemiological, serological and molecular biological data. Determination of titres of antibodies to EBV in serum-EBV-VCA-IgA, EBV - EA - IgA, and assay of EBV-DNA in tissue of patients with polymerase chain reaction (PCR) has been used for diagnosis of NPC. This paper evaluated the value of both assay mentioned above in the use for diganosis of NPC.85 patients were investigated.For each patient, determination of EBV- VCA-IgA(Ⅰ), EBV-EA-IgA (Ⅱ) in serum, EBV-DNA assay with PCR (Ⅲ) and histo-pathological examination (Ⅳ) of biopsy of nasopharyngeal tissue were performed with double-blind studies. 57 patients with NPC were confirmed by histo-pathopathological examination, and 28 patients were proven histo-logically non-NPC and served as control. Of 57 NPC, the positive rate of (Ⅰ). (Ⅱ ) or (Ⅲ) were 66.7%,21.1%,80.7% respectivelly,and (Ⅰ )+(Ⅱ), (Ⅰ)+(Ⅲ),(Ⅱ)+(Ⅲ),or(Ⅰ)+(Ⅱ)+(Ⅲ) were 21.1%, 56. 1%, 19.3%, 19.3% (P<0. 005).For 28 control cases, the negative rate of (Ⅰ ). (Ⅱ) or (Ⅲ)were 75%,100%, 100% respectivelly,and(Ⅰ)+(Ⅱ),(Ⅰ )+(Ⅲ), or (Ⅰ ) +(Ⅱ)+(Ⅲ)were 71.4%, 71.4%, 71.4% (P<0.005). Our results suggested that assay of EBV-DNA with PCR have best sensitivity (positive rate of NPC is high) and specificity (negative rate of control is high)for diagnosis of NPC and could be used in early diagnosis of NPC.
出处
《重庆医科大学学报》
CAS
CSCD
2000年第1期23-25,共3页
Journal of Chongqing Medical University
关键词
鼻咽癌
聚合酶链反应
EB病毒
诊断
DNA
Nasopharyngeal carcinoma
Epsten-Barr virus
Polymerase chain reaction